My topic is Pharmaceutical Video. In general terms these have failed to add the value originally anticipated as turning knowledge into safe and effective drugs is still a complicated, lengthy process. However, a wave of exciting monoclonal antibody products was being developed, and these were quickly partnered with big pharma which demonstrated the increasing commercial opportunity for biotechnology.Is this right information? I didn't get the right solution.
Any help will be appreciated.